Rodos BioTarget's Angel Round

Rodos BioTarget raised a round of funding on August 18, 2017. Investors include Otto Gies.

Rodos BioTarget (RBT) is a biopharmaceutical company developing a targeted drug delivery platform. RBT's TargoSphere technology enables carrying a broad range of active agents selectively into the cen…

Articles about Rodos BioTarget's Angel Round: